MENU
+Compare
BMEA
Stock ticker: NASDAQ
AS OF
Oct 8, 11:42 AM (EDT)
Price
$1.75
Change
-$0.10 (-5.41%)
Capitalization
158.89M

BMEA Biomea Fusion Forecast, Technical & Fundamental Analysis

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more

BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BMEA with price predictions
Oct 07, 2025

Aroon Indicator for BMEA shows an upward move is likely

BMEA's Aroon Indicator triggered a bullish signal on September 26, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 135 similar instances where the Aroon Indicator showed a similar pattern. In of the 135 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where BMEA advanced for three days, in of 237 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BMEA moved out of overbought territory on October 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 48 cases where BMEA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on October 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BMEA as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

BMEA moved below its 50-day moving average on October 07, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMEA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BMEA broke above its upper Bollinger Band on October 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.990) is normal, around the industry mean (23.421). P/E Ratio (0.000) is within average values for comparable stocks, (54.441). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.237). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (342.085).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BMEA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMEA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BMEA is expected to report earnings to fall 39.80% to -30 cents per share on November 04

Biomea Fusion BMEA Stock Earnings Reports
Q3'25
Est.
$-0.31
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.03
The last earnings report on August 05 showed earnings per share of -50 cents, beating the estimate of -54 cents. With 1.32M shares outstanding, the current market capitalization sits at 158.89M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
900 Middlefield Road
Phone
+1 650 980-9099
Employees
103
Web
https://www.biomeafusion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KLBAY6.720.06
+0.88%
Klabin S.A.
MTYFF27.96N/A
N/A
MTY Food Group, Inc.
INOQ9.00N/A
N/A
TPT Strategic Inc
IVBIY51.09N/A
N/A
Innovent Biologics Inc.
DCMDF0.99N/A
-0.30%
Data Communications Management Corp.

BMEA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with TCRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
-30.90%
TCRX - BMEA
39%
Loosely correlated
-3.90%
IDYA - BMEA
39%
Loosely correlated
-2.07%
CAI - BMEA
38%
Loosely correlated
-3.75%
CCCC - BMEA
37%
Loosely correlated
-0.88%
IMNM - BMEA
37%
Loosely correlated
-4.09%
More